SALT LAKE CITY, JANUARY 15, 2026—SPARC Health, a collaborative effort between Park City Angels (PCA), BioUtah, BioHive, in partnership with Governor’s Office of Economic Opportunity (GOEO), today announced applications are now open for its second cohort program. The announcement celebrates the impressive achievements of the inaugural cohort and the growing momentum of Utah’s healthcare innovation […]

3 Key takeaways   Participants gain a rare platform to pitch to a specialized panel of judges who possess the deep industry expertise required to fund and scale complex medical technologies, pharmaceuticals, and digital health solutions. Following in March, after the global JPMorgan Healthcare Conference, participating companies can take the “JPM momentum” and apply it […]

The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.

State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026

DiscGenics Treats First Patient in Phase 3 Clinical Trial of IDCT (Rebonuputemcel) for Symptomatic Mild-to-Moderate Lumbar Degenerative Disc Disease

Published in the journal PREGNANCY, the PRIME Study demonstrates significant improvements in neonatal outcomes with early risk screening and targeted interventions.

Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment